NFGAIL Amyloid Oligomers: The Onset of Beta-Sheet Formation and the Mechanism for Fibril Formation
- 22 December 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 140 (1) , 244-249
Abstract
The hexapeptide NFGAIL is a highly amyloidogenic peptide, derived from the human islet amyloid polypeptide (hIAPP). Recent investigations indicate that presumably soluble hIAPP oligomers are one of the cytotoxic species in type II diabe-tes. Here we use Thioflavin T staining, transmission electron microscopy as well as ion mobility-mass spectrometry coupled to infrared (IR) spectroscopy to study the amyloid formation mechanism and the quaternary- and secondary-structure of soluble NFGAIL oligomers. Our data reveal that at neutral pH NFGAIL follows a nucleation-dependent mechanism to form amyloid fibrils. During the lag phase, highly polydisperse, polymorph, and compact oligomers (oligomer number n=2-13) as well as extended intermediates (n=4-11) are present. IR secondary structural analysis reveals that compact conformations adopt turn-like structures, whereas extended oligomers exhibit a significant amount of β-sheet content. This agrees well with previous molecular dynamic simulations and provides direct experimental evidence that unordered off-pathway NFGAIL aggregates up to the size of at least the 13-mer as well as partially folded β-sheet containing oligomers are coexisting.Keywords
Funding Information
- Division of Chemistry (CHE-1565941)
- Deutscher Akademischer Austauschdienst
- Deutsche Forschungsgemeinschaft (SFB 1114)
- Alexander von Humboldt-Stiftung
This publication has 55 references indexed in Scilit:
- Islet amyloid: From fundamental biophysics to mechanisms of cytotoxicityFEBS Letters, 2013
- Aggregation of islet amyloid polypeptide: from physical chemistry to cell biologyCurrent Opinion in Structural Biology, 2013
- Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?Diabetologia, 2010
- Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer HypothesisEndocrine Reviews, 2008
- Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP–Induced β-Cell Apoptosis in h-IAPP Transgenic MiceDiabetes, 2007
- Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.Diabetes, 1999
- Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitusNature, 1994
- Possible Links Between Amylin and Diabetes: Amylin is released into the blood stream along with insulinDiabetes Care, 1992
- Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.Proceedings of the National Academy of Sciences, 1987
- ISLET AMYLOID FORMED FROM DIABETES-ASSOCIATED PEPTIDE MAY BE PATHOGENIC IN TYPE-2 DIABETESThe Lancet, 1987